conglobatin and Prostatic-Neoplasms

conglobatin has been researched along with Prostatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for conglobatin and Prostatic-Neoplasms

ArticleYear
Yeppoonic acids A - D: 1,2,4-trisubstituted arene carboxylic acid co-metabolites of conglobatin from an Australian Streptomyces sp.
    The Journal of antibiotics, 2022, Volume: 75, Issue:2

    Streptomyces sp. MST-91080 was isolated from a soil sample collected in Queensland, Australia. From this strain, yeppoonic acids A - D were purified and spectroscopically characterised. The yeppoonic acids are a family of diene enecarboxylic acids on a 1,2,4-trisubstituted benzene scaffold, structurally related to other Streptomyces secondary metabolites MF-EA-705α/β, NFAT-133 and the lorneic acids. Yeppoonic acids B and C show strong cytotoxicity against the NS-1 mouse myeloma cell line (IC

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Australia; Carboxylic Acids; Cell Line, Tumor; Humans; Male; Mice; Multiple Myeloma; Oxazoles; Prostatic Neoplasms; Queensland; Soil Microbiology; Streptomyces

2022